Notice of Award of a Single-Source Cooperative Agreement To Fund Burkina Faso Ministry of Health
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $450,000 for Year 1 of funding to the Burkina Faso Ministry of Health. to build laboratory and SI capacity to improve the provision of HIV testing, treatment, retention in line with HIV epidemic control and 95-95-95 targets (95% of HIV-positive individuals knowing their status, 95% of those receiving ART [Antiretroviral therapy], and 95% of those achieving viral suppression). Funding amounts for years 2-5 will be set at continuation.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 45 (Tuesday, March 8, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 45 (Tuesday, March 8, 2022)]
[Notices]
[Page 12966]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-04814]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single-Source Cooperative Agreement To Fund
Burkina Faso Ministry of Health
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $450,000 for Year 1 of funding to the Burkina
Faso Ministry of Health. to build laboratory and SI capacity to improve
the provision of HIV testing, treatment, retention in line with HIV
epidemic control and 95-95-95 targets (95% of HIV-positive individuals
knowing their status, 95% of those receiving ART [Antiretroviral
therapy], and 95% of those achieving viral suppression). Funding
amounts for years 2-5 will be set at continuation.
DATES: The period for this award will be September 30, 2022, through
September 29, 2027.
FOR FURTHER INFORMATION CONTACT: Trong Ao, Center for Global Health,
Centers for Disease Control and Prevention, CDC Ghana Office, U.S.
Embassy, 24 Fourth Circular Road, Cantonments, Accra Ghana, Telephone:
800-232-6348, Email: <a href="/cdn-cgi/l/email-protection#8df9ebecb5cdeee9eea3eae2fb"><span class="__cf_email__" data-cfemail="e1958780d9a1828582cf868e97">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The single-source award will support the
Burkina Faso Ministry of Health to implement HIV strategic information
and laboratory strengthening activities in Burkina Faso. The National
HIV/AIDS control program is one of the specialized programs within the
Ministry of Health. The Burkina Faso Ministry of Health is in a unique
position to conduct this work, as it functions under the Directorate of
Disease Prevention and control of the Ministry and is the mandated
institution to provide HIV treatment clinical services and guidelines
in Burkina Faso.
Summary of the Award
Recipient: Burkina Faso Ministry of Health.
Purpose of the Award: The purpose of this award is to build
laboratory and SI capacity to improve the provision of HIV testing,
treatment, retention in line with HIV epidemic control and 95-95-95
targets. This award strives to build and strengthen laboratories that
are equipped with the appropriate diagnostic technologies, trained and
skilled staff, and systems that can provide efficient services. It will
also strengthen SI systems, data quality assurance, and staff capacity
responsible for managing facility-based, survey and surveillance data
operating at national and subnational levels.
Amount of Award: The approximate year 1 funding amount will be
$450,000 in Federal Fiscal Year (FYY) 2022 funds, subject to the
availability of funds. Funding amounts for years 2-5 will be set at
continuation.
Authority: This program is authorized under Public Law 108-25 (the
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act
of 2003).
Period of Performance: September 30, 2022, through September 29,
2027.
Dated: March 2, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2022-04814 Filed 3-7-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.